Important Information

If you are interested in applying for this study, please:
  • Read the study description.
  • Review the Visit Planner dates in your location and confirm that you are available for the stated dates.
  • Complete the registration form below.

We will then contact you to check your suitability and share the Participant Informed Consent Form for you to read.

Study Information

New Zealand Clinical Research is trialling an investigational study device that could help people with Type 1 Diabetes.

You are invited to take part in a clinical research study evaluating an investigational device called Abbott’s Continuous Dual Glucose Ketone (DGK) Monitoring System. This device is designed to continuously monitor glucose and ketone levels in people with Type 1 diabetes.

The DGK Monitoring System is a wearable sensor placed just under the skin that continuously measures glucose and ketone levels. A compatible smartphone app is used to start the sensor and automatically receive glucose and ketone readings via Bluetooth. The system is intended for people aged 2 years and older with diabetes, including pregnant women. It provides real‑time readings, trends, and alerts when levels are too high or too low and may reduce the need for routine finger‑prick testing.

This study (2026 FULL 25709) is being funded by Abbott Diabetes Care, Inc. The ethical aspects of the study have been approved by the Health and Disability Ethics Committees (HDEC).

Requirements

  • Diagnosed with Type 1 Diabetes
  • Aged at least 2 years old
  • Please note other study criteria apply. Our research team will review your application based on our safety assessments and trial criteria.

What is Involved?

Study Visits: Up to 4 clinic visits.

Payment: $250 per visit before tax

Important Documents

Important documents to download and read

Pre-screening Form